{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:12:24Z","timestamp":1756383144975},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s42000-018-0029-1","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T11:53:12Z","timestamp":1525693992000},"page":"275-278","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Central precocious puberty in a case of late-diagnosed familial testotoxicosis and long-term treatment monitoring"],"prefix":"10.1007","volume":"17","author":[{"given":"Y\u0131lmaz","family":"Kor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"key":"29_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0889-8529(18)30288-3","volume":"20","author":"FJ Holland","year":"1991","unstructured":"Holland FJ (1991) Gonadotropin-independent precocious puberty. Endocrinol Metab Clin N Am 20:191\u2013210","journal-title":"Endocrinol Metab Clin N Am"},{"key":"29_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1210\/jcem-52-2-271","volume":"52","author":"HK Schedewie","year":"1981","unstructured":"Schedewie HK, Reiter EO, Beitins IZ, Seyed S, Wooten VD, Jimenez JF et al (1981) Testicular Leydig cell hyperplasia as a cause of familial sexual precosity. J Clin Endocrinol Metab 52:271\u2013278","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/365652a0","volume":"365","author":"A Shenker","year":"1993","unstructured":"Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler GB (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652\u2013654","journal-title":"Nature"},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2265.2007.03160.x","volume":"69","author":"MQ Almeida","year":"2008","unstructured":"Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M, Antonini SR et al (2008) Long-term treatment of familial male limited precocious puberty (testotoxicosis) with cyproteroneacetate or ketoconazole. Clin Endocrinol 69:93\u201398","journal-title":"Clin Endocrinol"},{"key":"29_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJM198504183121604","volume":"312","author":"FJ Holland","year":"1985","unstructured":"Holland FJ, Fishman L, Bailey JD, Fazekas AT (1985) Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N Engl J Med 312:1023\u20131028","journal-title":"N Engl J Med"},{"key":"29_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1210\/jc.2004-1438","volume":"90","author":"L Soriano-Guillen","year":"2005","unstructured":"Soriano-Guillen L, Lahlou N, Chauvet G, Roger M, Chaussain JL, Carel JC (2005) Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty. J Clin Endocrinol Metab 90:147\u2013151","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1210\/jcem-57-3-571","volume":"57","author":"SM Rosenthal","year":"1983","unstructured":"Rosenthal SM, Grumbach MM, Kaplan SL (1983) Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxy progesterone acetate therapy in four cases. J Clin Endocrinol Metab 57:571\u2013579","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000282913","volume":"57","author":"K Itoh","year":"1996","unstructured":"Itoh K, Nakada T, Kubota Y, Suzuki H, Ishigooka M, Izumi T (1996) Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate. Urol Int 57:199\u2013202","journal-title":"Urol Int"},{"key":"29_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jpeds.2006.04.027","volume":"149","author":"NC Kreher","year":"2006","unstructured":"Kreher NC, Pescovitz OH, Delameter P, Tiulpakov A, Hochberg Z (2006) Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr 149:416\u2013420","journal-title":"J Pediatr"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1515\/jpem.2010.161","volume":"23","author":"EO Reiter","year":"2010","unstructured":"Reiter EO, Mauras N, McCormick K, Kulshreshtha B, Arnrhein J, De Luca F et al (2010) Bicalutamide plus anastrozole for theTreatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). J Pediatr Endocrinol Metab 23:999\u20131009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1515\/jpem-2006-190413","volume":"19","author":"M Teles","year":"2006","unstructured":"Teles M, Brito VN, Arnhold IJ, Mendonca BB, Latronico AC (2006) Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor. J Pediatr Endocrinol Metab 19:541\u2013544","journal-title":"J Pediatr Endocrinol Metab"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4274\/jcrpe.2067","volume":"7","author":"B Ozcab\u0131","year":"2015","unstructured":"Ozcab\u0131 B, Tahmiscio\u011flu Bucak F, Ceylaner S, Rah\u015fan O, Buyukunal C, Ercan O et al (2015) Testotoxicosis: report of two cases, one with a novel mutation in LHCGR gene. J Clin Res Pediatr Endocrinol 7:242\u2013248","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1507\/endocrj.K10E-227","volume":"57","author":"K Nagasaki","year":"2010","unstructured":"Nagasaki K, Katsumata N, Ogawa Y, Kikuchi T, Uchiyama M (2010) Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone\/chorio gonadotropin receptor in a Japanese boy with peripheral precocious puberty. Endocr J 57:1055\u20131060","journal-title":"Endocr J"},{"key":"29_CR14","first-page":"151","volume":"76","author":"L Laue","year":"1993","unstructured":"Laue L, Jones J, Barnes KM, Cutler GB (1993) Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. J Clin Endocrinol Metab 76:151\u2013155","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1210\/jcem.84.1.5413","volume":"84","author":"EW Leschek","year":"1999","unstructured":"Leschek EW, Jones J, Barnes KM, Hill SC, Cutler GB (1999) Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. J Clin Endocrinol Metab 84:175\u2013178","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-018-0029-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:28:22Z","timestamp":1720279702000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s42000-018-0029-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s42000-018-0029-1","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,7]]},"assertion":[{"value":"18 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}